Patents Assigned to GABA THERAPEUTICS INC.
  • Deuterated analogs of etifoxine, their derivatives and uses thereof
    Patent number: 11672805
    Abstract: This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions containing the same.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: June 13, 2023
    Assignee: GABA THERAPEUTICS INC.
    Inventor: Olivier Dasse
  • Deuterated analogs of etifoxine, their derivatives and uses thereof
    Patent number: 10736901
    Abstract: This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions containing the same.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: August 11, 2020
    Assignee: GABA THERAPEUTICS INC.
    Inventor: Olivier Dasse